Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | MGLL | Q99685 | 2/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL787107 | 1.00 | TSHR (0.48) | TSHRALDH1A1ALOX5FAAHMGLL | |
| SCHEMBL27601371 | 1.00 | TSHR (0.48) | TSHRALDH1A1ALOX5FAAHMGLL | |
| SCHEMBL6229884 | 1.00 | TSHR (0.48) | TSHRALDH1A1ALOX5FAAHMGLL | |
| SCHEMBL3674032 | 1.00 | TSHR (0.48) | TSHRALDH1A1ALOX5FAAHMGLL | |
| Hexadecane SCHEMBL369966 | 0.92 | ALOX5 (0.42) | TSHRALDH1A1ALOX5FAAHMGLL | |
| SCHEMBL22973525 | 0.92 | ALOX5 (0.42) | TSHRALDH1A1ALOX5FAAHMGLL | |
| SCHEMBL27962943 | 0.84 | ALOX5 (0.37) | ALDH1A1ALOX5FAAHMGLL | |
| 1-Pentanol SCHEMBL28649677 | 0.83 | SMN1; SMN2 (0.38) | TSHRALDH1A1ALOX5FAAHMGLL | |
| SCHEMBL1569225 | 0.82 | BRD4 (0.39) | TSHRALDH1A1 | |
| SCHEMBL11109025 | 0.82 | EP300 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080113032-A1 | Scalp Desensitizing Formulation | BMM POWERMOVES, LLC (US) | 2008-05-15 | — | — | US | claimed |
| US-20030049283-A1 | Scalp desensitizing formulation | BMM POWERMOVES, LLC | 2003-03-13 | — | — | US | claimed |
| EP-0838498-B1 | CARBOXYLATED POLYMER COMPOSITION | SUMITOMO SEIKA CHEMICALS (JP) | 2002-11-13 | — | — | EP | claimed |
| WO-1996002577-A1 | RESPONSIVE POLYMER GEL BEADS | GEL SCIENCES, INC. (US) | 1996-02-01 | — | — | WO | claimed |
| WO-2024059862-A2 | FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS | EVOLVED BY NATURE, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023201208-A1 | 1,3-BUTYLENE GLYCOL COMPOSITIONS AND METHODS OF USE | GENOMATICA, INC. (US) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023069956-A1 | SILK STIMULATED COLLAGEN AND CLAUDIN-1 EXPRESSION, AND SILK STIMULATED ANTI-INFLAMMATORY EFFECTS | EVOLVED BY NATURE, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| CN-111356674-B | Novel ceramide-like compounds having improved stability and compositions comprising the same | 爱敬产业株式会社 | 2022-12-23 | — | — | CN | disclosed |
| US-20220401335-A1 | SILK HAIR CARE COMPOSITIONS | EVOLVED BY NATURE, INC. (US) | 2022-12-22 | — | — | US | disclosed |
| EP-3955886-A1 | SILK HAIR CARE COMPOSITIONS | Evolved by Nature, Inc. (US) | 2022-02-23 | — | — | EP | disclosed |
| WO-2020247887-A1 | SILK STIMULATED COLLAGEN PRODUCTION AND METHODS OF USE THEREOF | EVOLVED BY NATURE, INC. (US) | 2020-12-10 | — | — | WO | disclosed |
| WO-2020214854-A1 | SILK HAIR CARE COMPOSITIONS | EVOLVED BY NATURE, INC. (US) | 2020-10-22 | — | — | WO | disclosed |
| WO-2004112732-A2 | MODIFIED SOY PROTEINS IN SKIN TIGHTENING COMPOSITIONS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2004-12-29 | — | — | WO | disclosed |
| WO-2004112745-A1 | MODIFIED SOY PROTEINS IN PERSONAL CARE COMPOSITIONS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2004-12-29 | — | — | WO | disclosed |
| US-20040170590-A1 | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-09-02 | — | — | US | disclosed |
| US-6497889-B2 | CONTAINING HYDROXYPROLINE COMPOUND | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-12-24 | — | — | US | disclosed |
| US-20020009472-A1 | Cosmetics | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1166767-A2 | Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-0414073-A2 | Process for the preparation of polyurethane powders | BAYER AG (DE) | 1991-02-27 | — | — | EP | disclosed |
| EP-0414085-A2 | Surface-active copolymers and their use in the preparation of polyurethane powders | BAYER AG (DE) | 1991-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220401335-A1 | SILK HAIR CARE COMPOSITIONS | CUTA, KRT18, MATR3 | TSHR 4397/4885ALDH1A1 3906/4885ALOX5 2157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.